📢First-Ever PADO for #RSV Report Released! . Led by @WHO, it sets key R&D + access priorities to prevent & treat #RSV in kids over the next 3–10 yrs. Find out more👇#Bettermeds4kids.

Looking forward to welcoming you all to the launch today. There is still time to register here

📢 Join us for the next #BetterMeds4Kids webinar!. 🗓️ 8 July 2025 | 🕑 14:00–15:00 CEST.🌍 Topic: Optimizing tools for the prevention and treatment of RSV disease in children: Priorities and the Path Forward.📄 Featuring the launch of GAP-f’s PADO report on RSV. 🔗 Register now:

📣GAP-f has just launched its 2025–2030 Strategy with a bold goal:. ✅ 10 diseases. ✅ 10 medicines. ✅ 10 countries. All by 2030. Because every child deserves timely access to the medicines they need. 📄 Learn more 👉WHO launches global accelerator for Paediatric Formulations

🔍 New study reveals critical gaps in paediatric medicines on national essential medicines lists—especially in LMICs. Our children’s health is at risk. This is why our collective work is more important than ever. 🚨 It's time for equitable access to #BetterMeds4Kids. 📖 Read.

📢Join us at the 78th World Health Assembly for a high-level side event on advancing access to paediatric medicines!.📅 20 May 2025, .🕰️18:30–20:30 CET at Jardin de Penthes, Geneva.🚀Let's strengthen the global ecosystem for #children's #health together!.🔗

📢Just published in The Lancet Child & Adolescent Health!. "Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas". 💊 A step toward simplifying and standardising paediatric treatment globally. 📄 Read: #ChildHealth.

📢 The Target Product Profiles for priority #paediatric formulations of azithromycin & nitrofurantoin are now available! 📄👇.🔗 Interested #Manufacturers are invited to submit an EOI for product evaluation to #WHO.🔗 Please see

We look forward to seeing you all at the webinar today! There is still time to register 👉📄 Agenda 👇

📢 Save the date! Join us for our upcoming webinar on Investigating and developing better antibiotics for children: What Can We Do Now and Next? . 📅 March 4, 2025.⏰1400-1500 CET. Register here 👉

🎉 We are excited to share our recently published meeting report from the first Paediatric Drug Optimization (PADO) meeting for childhood cancer medicines. 📑This report outlines the discussions & outcomes of the @GAP_f_Network @WHO-led PADO process, a strategic approach to

Advancing #paediatric formulations is crucial to ensure equitable, evidence-based care for #children with serious bacterial infections. The report on #WHO's technical consultation which aims to facilitate regulatory pathways to accelerate access to effective treatments is

🧒💊 19 of the 27 essential medicines for #NTDs in the WHO Essential Medicines for Children lack child-friendly formulations. 📘 Discover more in the new Paediatric R&D Landscape for Neglected Tropical Diseases report: Read 👇 #NTDs #Bettermeds4kids

🌍 This #WorldChildrensDay, we are proud to share the GAP-f Phase 2 Progress Report! The 📰highlights progress, challenges, and lessons learned, preparing us for GAP-f's next strategic phase. Read more here 👉

RT @MedsPatentPool: 🌍This #WorldPneumoniaDay, we must address the ongoing battle against #RSV, a leading cause of severe respiratory infect….

RT @gardp_amr: Children of all ages are overlooked in the global #AMR response🛑. Our new policy paper details the extent of this crisis and….

📢Call for public consultation: Target product profile for paediatric formulation of Nitrofurantoin and Azithromycin.📅Deadline: 13 November . Find out more 👉Call for public consultation: Target product profile for paediatric formulation of Nitrofurantoin and Azithromycin.

Looking forward to seeing you all tomorrow for our webinar which launches GAP-f's product introduction toolkit. Register 👉 to attend!. @teampata @EGPAF @UNICEF.

📢Join us for our third webinar of 2024 for the GAP-f #BetterMeds4Kids webinar series on Accelerating the introduction of new paediatric products - An overview of GAP-f’s product introduction toolkit and its practical application. 📅 3 October 2024 .🕑 1400 CEST.register

📢We call on #WHO Member States and other relevant stakeholders to share good policy practices & solutions & advocate for the prioritization of #children’s needs in global, regional and national debates on access to medicines 🌍🧒🏾👧🏾. ❓What is your call?. 🫱🏽‍🫲🏾Let’s join efforts to